[HTML][HTML] Sclerostin levels in CKD patients: an important, but not definitive, step on the way to clinical use

P Delanaye, E Cavalier, A Bouquegneau, A Khwaja - Kidney International, 2015 - Elsevier
Sclerostin, an inhibitor of the Wnt signaling pathway, inhibits bone formation. In a study of
vascular biopsies of patients undergoing kidney transplantation, Qureshi et al. demonstrate …

Sclerostin levels in CKD patients: an important, but not definitive, step on the way to clinical use

P Delanaye, E Cavalier… - Kidney …, 2015 - pubmed.ncbi.nlm.nih.gov
Sclerostin, an inhibitor of the Wnt signaling pathway, inhibits bone formation. In a study of
vascular biopsies of patients undergoing kidney transplantation, Qureshi et al. demonstrate …

Sclerostin levels in CKD patients: an important, but not definitive, step on the way to clinical use.

P Delanaye, E Cavalier, A Bouquegneau… - Kidney …, 2015 - europepmc.org
Sclerostin, an inhibitor of the Wnt signaling pathway, inhibits bone formation. In a study of
vascular biopsies of patients undergoing kidney transplantation, Qureshi et al. demonstrate …

[HTML][HTML] Sclerostin levels in CKD patients: an important, but not definitive, step on the way to clinical use

P Delanaye, E Cavalier, A Bouquegneau… - Kidney …, 2015 - kidney-international.org
Sclerostin, an inhibitor of the Wnt signaling pathway, inhibits bone formation. In a study of
vascular biopsies of patients undergoing kidney transplantation, Qureshi et al. demonstrate …

[引用][C] Sclerostin levels in CKD patients: an important, but not definitive, step on the way to clinical use

P DELANAYE, E CAVALIER, A BOUQUEGNEAU… - Kidney …, 2015 - orbi.uliege.be
ORBi: Detailled Reference institution logo Login EN [EN] English [FR] Français logo Login
EN [EN] English [FR] Français Give us feedback Explore SearchSpecial collections …

[引用][C] Sclerostin levels in CKD patients: an important, but not definitive, step on the way to clinical use

P Delanaye, E Cavalier… - Kidney …, 2015 - Nature Publishing Group